Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
0.990
-0.060 (-5.70%)
At close: Nov 21, 2024, 4:00 PM
1.000
+0.010 (0.99%)
After-hours: Nov 21, 2024, 4:05 PM EST
CNTB Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Cash & Equivalents | 110.17 | 106.01 | 79.01 | 267.72 | 1,010 | 308.97 | Upgrade
|
| Short-Term Investments | 0.07 | 12.7 | 73.46 | - | 3.88 | 4.44 | Upgrade
|
| Trading Asset Securities | - | - | - | - | 13.07 | 30.63 | Upgrade
|
| Cash & Short-Term Investments | 110.24 | 118.7 | 152.47 | 267.72 | 1,027 | 344.04 | Upgrade
|
| Cash Growth | -15.93% | -22.14% | -43.05% | -73.93% | 198.52% | -20.28% | Upgrade
|
| Other Receivables | - | - | - | 7.41 | - | - | Upgrade
|
| Receivables | 3.56 | - | - | 7.41 | - | - | Upgrade
|
| Prepaid Expenses | 2.1 | 2.27 | 3.31 | - | 29.77 | 18.77 | Upgrade
|
| Total Current Assets | 115.9 | 120.97 | 155.78 | 275.13 | 1,057 | 362.81 | Upgrade
|
| Property, Plant & Equipment | 4.52 | 4.73 | 8.47 | 12.89 | 7.87 | 3.42 | Upgrade
|
| Long-Term Investments | - | - | 9.44 | - | - | - | Upgrade
|
| Other Intangible Assets | 0.06 | 0.06 | 0.07 | 0.09 | 0.34 | - | Upgrade
|
| Other Long-Term Assets | 0.1 | 0.13 | 0.25 | 2.95 | 19.86 | 6.35 | Upgrade
|
| Total Assets | 120.57 | 125.89 | 174.01 | 291.05 | 1,085 | 372.59 | Upgrade
|
| Accounts Payable | 5.7 | 7.66 | 11.94 | 12.74 | 24.64 | 22.79 | Upgrade
|
| Accrued Expenses | 3.16 | 2.56 | 2.96 | - | 12.21 | 4.02 | Upgrade
|
| Current Portion of Leases | 0.25 | 0.29 | 0.19 | 0.1 | 0.6 | 0.41 | Upgrade
|
| Current Unearned Revenue | - | 13.32 | - | - | - | - | Upgrade
|
| Other Current Liabilities | 0.51 | 0.44 | 0.54 | 5.15 | 0.54 | 0.18 | Upgrade
|
| Total Current Liabilities | 9.62 | 24.26 | 15.62 | 17.99 | 38 | 27.4 | Upgrade
|
| Long-Term Debt | - | - | - | - | 2,072 | 643.01 | Upgrade
|
| Long-Term Leases | 0.07 | 0.18 | 0.25 | 0.03 | 0.31 | 0.47 | Upgrade
|
| Long-Term Unearned Revenue | 0.39 | 0.41 | 0.65 | 0.78 | - | - | Upgrade
|
| Total Liabilities | 10.09 | 24.85 | 16.52 | 18.8 | 2,110 | 670.88 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 628.87 | 628.71 | 628.66 | 628.64 | 41.47 | 38.12 | Upgrade
|
| Retained Earnings | -531.7 | -539.35 | -479.84 | -361.75 | -1,071 | -292.12 | Upgrade
|
| Treasury Stock | -0.18 | -0.18 | -0.18 | -0.18 | -0 | -0 | Upgrade
|
| Comprehensive Income & Other | 13.48 | 11.85 | 8.85 | 5.54 | 4.91 | -44.31 | Upgrade
|
| Shareholders' Equity | 110.48 | 101.04 | 157.49 | 272.26 | -1,025 | -298.29 | Upgrade
|
| Total Liabilities & Equity | 120.57 | 125.89 | 174.01 | 291.05 | 1,085 | 372.59 | Upgrade
|
| Total Debt | 0.33 | 0.47 | 0.43 | 0.13 | 2,072 | 643.89 | Upgrade
|
| Net Cash (Debt) | 109.92 | 118.24 | 152.04 | 267.59 | -1,045 | -299.85 | Upgrade
|
| Net Cash Growth | -15.80% | -22.23% | -43.18% | - | - | - | Upgrade
|
| Net Cash Per Share | 1.99 | 2.15 | 2.76 | 5.13 | -61.17 | -17.77 | Upgrade
|
| Filing Date Shares Outstanding | 55.25 | 55.1 | 55.04 | 55.08 | 17.09 | 16.81 | Upgrade
|
| Total Common Shares Outstanding | 55.25 | 55.1 | 55.04 | 55.08 | 17.09 | 16.81 | Upgrade
|
| Working Capital | 106.27 | 96.71 | 140.16 | 257.14 | 1,019 | 335.42 | Upgrade
|
| Book Value Per Share | 2.00 | 1.83 | 2.86 | 4.94 | -59.97 | -17.75 | Upgrade
|
| Tangible Book Value | 110.42 | 100.98 | 157.42 | 272.17 | -1,025 | -298.29 | Upgrade
|
| Tangible Book Value Per Share | 2.00 | 1.83 | 2.86 | 4.94 | -59.99 | -17.75 | Upgrade
|
| Machinery | 6.11 | 5.84 | 5.84 | 5.77 | 6.26 | 3.64 | Upgrade
|
| Construction In Progress | - | - | - | 3.7 | 1.91 | - | Upgrade
|
| Leasehold Improvements | 0.76 | 0.76 | 0.76 | 0.73 | 1.46 | 0.63 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.